Optimal clinical pathway for the patient with type B acute aortic dissection

Area of Science:

• Cardiovascular Medicine
• Thoracic Surgery
• Medical Treatment Protocols

Background:

• Traditional management for type B acute aortic dissection (AAD) lacks confirmed optimal clinical pathways.
• 210 patients with uncomplicated type B AAD were studied over 12 years.
• Conventional therapy involved 7 days of bed rest and IV antihypertensives.

Purpose of the Study:

• To evaluate the safety and efficacy of an early rehabilitation clinical pathway for type B AAD.
• To compare outcomes between conventional therapy and the new clinical pathway.
• To assess the impact on early complications and aortic diameter.

Main Methods:

• Patients were divided into a Conventional Therapy Group (CG, n=90) and a Clinical Pathway Group (CPG, n=120).
• CPG received oral medication on day 1 and early ambulation from day 3.
• Outcomes including complications, mortality, and aortic diameter were monitored.

Main Results:

• The CPG showed significantly decreased incidence of respiratory complications and delirium.
• Early mortality rates were similar between CG (3.3%) and CPG (2.5%).
• No aortic enlargement was observed in either group at 1-month follow-up.

Conclusions:

• The clinical pathway for uncomplicated type B AAD is safer than traditional methods.
• Early rehabilitation in the CPG effectively prevents early complications.
• The clinical pathway offers a cost benefit and improved patient outcomes.